Li P K, Poon A S, Lai K N
Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin.
Kidney Int. 1994 Jul;46(1):185-90. doi: 10.1038/ki.1994.258.
We have studied the restriction fragment length polymorphism (RFLP) of the major histocompatibility complex (MHC) class II DQ and DR regions of 79 Chinese patients with IgA nephropathy (IgAN) and compared it with 104 normal Chinese controls. The DR and DQ alleles were confirmed by polymerase chain reaction using sequence specific primers. There was a significantly higher frequency of homozygous DQ beta 3b (DQ7) in patients with IgAN (16.4%) compared with controls (5.7%). Seventy-one IgAN patients had their renal biopsies graded according to histopathological severity: grades I, II or III. There was no statistical difference in the DR and DQ alleles among the three grades. Seventy-three patients were classified into group A with normal and stable renal function (serum creatinine < or = 150 mumol/liter) and group B with chronic renal failure (serum creatinine > 150 mumol/liter). There was a significant increase in frequency of DQA2 U (DX alpha U) allele in group B (66.9%) compared with group A (26.9%). Also, there was an increased frequency of DQ alpha 2 allele in the group A (40.4%) compared with group B (14.3%). Out of the 24 patients carrying the DQ alpha 2 allele, 17 were DQA2 U allele-negative and they all had normal renal function, suggesting that DQA2 U allele is associated with a poor prognostic factor in IgAN. The study shows that DQ alleles are probably the important genetic loci or are close markers for the disease susceptibility and prognostic index for IgAN in Chinese people.
我们研究了79例中国IgA肾病(IgAN)患者主要组织相容性复合体(MHC)II类DQ和DR区域的限制性片段长度多态性(RFLP),并与104名正常中国对照者进行了比较。使用序列特异性引物通过聚合酶链反应确认DR和DQ等位基因。与对照组(5.7%)相比,IgAN患者中纯合DQβ3b(DQ7)的频率显著更高(16.4%)。71例IgAN患者根据组织病理学严重程度对肾活检进行分级:I级、II级或III级。三个级别之间的DR和DQ等位基因无统计学差异。73例患者分为肾功能正常且稳定(血清肌酐≤150μmol/L)的A组和慢性肾衰竭(血清肌酐>150μmol/L)的B组。与A组(26.9%)相比,B组中DQA2 U(DXαU)等位基因的频率显著增加(66.9%)。此外,与B组(14.3%)相比,A组中DQα2等位基因的频率增加(40.4%)。在携带DQα2等位基因的24例患者中,17例为DQA2 U等位基因阴性,且他们的肾功能均正常,这表明DQA2 U等位基因与IgAN的不良预后因素相关。该研究表明,DQ等位基因可能是中国人IgAN疾病易感性和预后指标的重要基因位点或紧密标记。